Vaccine Manufacturing and Innovation Centre: Sales

Department for Science, Innovation and Technology written question – answered at on 17 March 2023.

Alert me about debates like this

Photo of Chris Green Chris Green Conservative, Bolton West

To ask the Secretary of State for Science, Innovation and Technology, how much revenue was raised for the Exchequer by the sale of the Vaccines Manufacturing Innovation Centre; and whether those funds will be reinvested into life sciences manufacturing capabilities in the UK.

Photo of George Freeman George Freeman Minister of State (Department for Science, Innovation and Technology)

The Vaccine Taskforce granted funding to VMIC Ltd to support development of the Vaccine Manufacturing and Innovation Centre, a vaccine research and manufacturing facility in Harwell.

In late 2021, VMIC UK Ltd's Board of Directors made the decision to sell the facility through a competitive process. In April 2022, the facility was sold to Catalent. VMIC Ltd subsequently entered a voluntary liquidation.

The courts appointed liquidators to act on behalf of creditors and this process is under way. It is not possible to comment on the question of revenue raised while the liquidation process is ongoing.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.